Given that reducing the level of Cdk5 in astrocytes could protect against brain damage in cerebrovascular diseases (Becerra-Calixto et al., 2018), it is believed that Cdk5 has great potential in the treatment of ischemic stroke. Here, CDK5 is linked to ischemic stroke.